Analyst firms · Wedbush · RZLT
Wedbush RZLT price target and rating history
Rezolute Inc. (RZLT) · Health Care
Wedbush rates Rezolute Inc. (RZLT) Outperform with a $5 price target, as of its latest action on Mar 25, 2026. It has published 3 rating actions on RZLT since November 2024, including 1 upgrade and 1 downgrade. Across 4 firms with a RZLT price target in the last 12 months, the median target is $8. Wedbush's $5 is 37% below that.
- Current rating
- Outperform
- Price target
- $5
- Median target, all firms
- $8
- Actions on RZLT
- 3
Wedbush price target on RZLT
Every Wedbush rating on RZLT
- Mar 25, 2026
- Dec 11, 2025
- Nov 5, 2024
How other firms rate RZLT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Cantor Fitzgerald | Overweight | Oct 6, 2026 | |
| Lake Street | Buy | $9 | Sep 30, 2026 |
| Craig-Hallum | Buy | $7 | Sep 29, 2026 |
| Citizens JMP | Mkt Outperform | $11 | Jun 3, 2026 |
| Wedbush | Outperform | $5 | Mar 25, 2026 |
Questions about Wedbush and RZLT
- What is Wedbush's price target for RZLT?
- Wedbush's latest stated price target for Rezolute Inc. (RZLT) is $5, from its action on Mar 25, 2026.
- What is Wedbush's rating on RZLT?
- Wedbush rates RZLT Outperform, a bullish rating, as of Mar 25, 2026.
- When did Wedbush last change its view on RZLT?
- On Mar 25, 2026, Wedbush upgrades to Outperform from Neutral, price target $5.
- How does Wedbush's RZLT target compare with other analysts?
- Across 4 firms with a RZLT price target in the last 12 months, the median target is $8. Wedbush's $5 is 37% below that.
More RZLT rating histories
All Wedbush ratingsRZLT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.